SXT Stock Analysis: Sensient Technologies | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 5.474m USD | 12M Return: 44.1% | US81725T1007 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 41.2M
EPS Trend: 90.7%
Qual. Beats: 2
Rev. Trend: 98.6%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Sensient Technologies Corporation (NYSE: SXT) is a global manufacturer and supplier of specialty ingredients, operating through three business segments: Flavors & Extracts, Color, and Asia Pacific. The company serves the food, beverage, personal care, pharmaceutical, nutraceutical, and industrial markets with products such as flavor systems, natural and synthetic colors, dehydrated agricultural ingredients, essential oils, and excipients. It also produces and distributes chili powder, paprika, chili pepper, and parsley products under well-known brands including Sensient Flavors, Sensient Food Colors, Sensient Pharmaceutical, and Sensient Beauty.
Headquartered in Milwaukee, Wisconsin, and incorporated in 1882, Sensient is classified within the Specialty Chemicals sub-industry of the Materials sector. Its business model is built on proprietary ingredient formulation and B2B sales to consumer goods manufacturers, with a geographic footprint that includes a dedicated Asia Pacific segment covering the Pacific Rim and India.
- FDA synthetic dye restrictions boost natural color demand
- Flavors and Extracts segment drives revenue and margin expansion
- Asia Pacific revenue accelerates on emerging market demand
| Net Income: 158.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -2.67 > 1.0 |
| NWC/Revenue: 53.66% < 20% (prev 51.72%; Δ 1.93% < -1%) |
| CFO/TA 0.05 > 3% & CFO 123.4m > Net Income 158.0m |
| Net Debt (732.9m) to EBITDA (270.1m): 2.71 < 3 |
| Current Ratio: 4.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (42.7m) vs 12m ago 0.45% < -2% |
| Gross Margin: 34.65% > 18% (prev 33.28%; Δ 1.36% > 0.5%) |
| Asset Turnover: 74.46% > 50% (prev 71.47%; Δ 2.99% > 0%) |
| Interest Coverage Ratio: 7.74 > 6 (EBIT TTM 239.3m / Interest Expense TTM 30.9m) |
| A: 0.39 (Total Current Assets 1.18b - Total Current Liabilities 269.6m) / Total Assets 2.37b |
| B: 0.80 (Retained Earnings 1.91b / Total Assets 2.37b) |
| C: 0.10 (EBIT TTM 239.3m / Avg Total Assets 2.29b) |
| D: 1.13 (Book Value of Equity 1.26b / Total Liabilities 1.11b) |
| Altman-Z'' = 7.05 = AAA |
| DSRI: 1.04 (Receivables 376.5m/334.0m, Revenue 1.70b/1.58b) |
| GMI: 0.96 (GM 33.28% / 34.65%) |
| AQI: 0.91 (AQ_t 0.26 / AQ_t-1 0.28) |
| SGI: 1.08 (Revenue 1.70b / 1.58b) |
| TATA: 0.01 (NI 158.0m - CFO 123.4m) / TA 2.37b) |
| Beneish M = -3.02 (Cap -4..+1) = AA |
As of October 07, 2026, the stock is trading at USD 132.91 with a total of 408,200 shares traded. Over the past week, the price has changed by +3.26%, over one month by -0.76%, over three months by +7.14% and over the past year by +44.14%.
Current recommended Stop Loss: 125.70 (which is 5.4% or 2.4 ATR below the current price).
Sensient Technologies has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy SXT.
- StrongBuy: 2
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 144.4 | 8.6% |
P/E Trailing = 34.1995
P/E Forward = 22.7273
P/S = 3.2129
P/B = 4.419
P/EG = 1.7352
Revenue TTM = 1.70b USD
EBIT TTM = 239.3m USD
EBITDA TTM = 270.1m USD
Long Term Debt = 763.5m USD (from longTermDebt, last quarter)
Short Term Debt = 397k USD (from shortTermDebt, last quarter)
Debt = 763.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 732.9m USD (calculated: Debt 763.9m - CCE 31.0m)
Enterprise Value = 6.21b USD (5.47b + Debt 763.9m - CCE 31.0m)
Interest Coverage Ratio = 7.74 (Ebit TTM 239.3m / Interest Expense TTM 30.9m)
EV/FCF = 1000.0x (Enterprise Value 6.21b / FCF TTM 4.48m)
FCF Yield = 0.07% (FCF TTM 4.48m / Enterprise Value 6.21b)
FCF Margin = 0.26% (FCF TTM 4.48m / Revenue TTM 1.70b)
Net Margin = 9.27% (Net Income TTM 158.0m / Revenue TTM 1.70b)
Gross Margin = 34.65% ((Revenue TTM 1.70b - Cost of Revenue TTM 1.11b) / Revenue TTM)
Gross Margin QoQ = 37.40% (prev 35.03%)
Tobins Q-Ratio = 2.62 (Enterprise Value 6.21b / Total Assets 2.37b)
Interest Expense / Debt = 4.05% (Interest Expense 30.9m / Debt 763.9m)
Taxrate = 24.20% (50.4m / 208.4m)
NOPAT = 181.4m (EBIT 239.3m * (1 - 24.20%))
Current Ratio = 4.39 (Total Current Assets 1.18b / Total Current Liabilities 269.6m)
Debt / Equity = 0.61 (Debt 763.9m / totalStockholderEquity, last quarter 1.26b)
Debt / EBITDA = 2.71 (Net Debt 732.9m / EBITDA 270.1m)
Debt / FCF = 163.5 (Net Debt 732.9m / FCF TTM 4.48m)
Total Stockholder Equity = 1.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.90% (Net Income 158.0m / Total Assets 2.37b)
RoE = 13.02% (Net Income TTM 158.0m / Total Stockholder Equity 1.21b)
RoCE = 12.11% (EBIT 239.3m / Capital Employed (Equity 1.21b + L.T.Debt 763.5m))
RoIC = 8.76% (NOPAT 181.4m / Invested Capital 2.07b)
WACC = 6.43% (E(5.47b)/V(6.24b) * Re(6.90%) + D(763.9m)/V(6.24b) * Rd(4.05%) * (1-Tc(0.24)))
Discount Rate = 6.90% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 97.27 | Cagr: 0.43%
[DCF] Terminal Value 73.10% ; FCFF base≈27.9m ; Y1≈24.5m ; Y5≈19.8m
[DCF] Fair Price = N/A (negative equity: EV 317.7m - Net Debt 732.9m = -415.2m; debt exceeds intrinsic value)
EPS Correlation: 90.68 | EPS CAGR: 11.60% | SUE: 2.48 | # QB: 2
Revenue Correlation: 98.60 | Revenue CAGR: 5.62% | SUE: 1.36 | # QB: 2
EPS current Quarter (2026-09-30): EPS=1.09 | Chg30d=-0.09% | Revisions=+40% | Analysts=3
EPS current Year (2026-12-31): EPS=4.18 | Chg30d=-0.04% | Revisions=+57% | GrowthEPS=+20.1% | GrowthRev=+11.8%
EPS next Year (2027-12-31): EPS=4.96 | Chg30d=+0.01% | Revisions=+62% | GrowthEPS=+18.6% | GrowthRev=+13.7%
[Analyst] Revisions Ratio: +79% (up=11, down=0)